Company profile
Remedy Robotics
Remedy Robotics develops robotic systems for endovascular intervention. Its N1 system is built for remote neurovascular and cardiovascular procedures, givi...
Facts
- Segment
- SURGICAL
- Country
- United States
- Headquarters
- San Francisco
- Founded
- 2020
- Website
- https://www.remedyrobotics.com/
About Remedy Robotics
Remedy Robotics develops robotic systems for catheter-based endovascular intervention. Its N1 platform gives clinicians precise control of wires and catheters for neurovascular and cardiovascular procedures, with a remote architecture intended to extend specialist treatment beyond the room where the patient is located.
The system targets stroke, aneurysm, internal bleeding and other vascular conditions where speed and fine instrument movement matter. Remedy combines robotic hardware, imaging integration, controls and clinical workflow design and is progressing through preclinical and regulatory development. Commercial use will depend on clearance for specific procedures and operating configurations.
Market context
DEVELOPMENT
Summary
Type: Surgical robotics
Core: N1 system
Function: Surgery
Audience: Healthcare providers
Research, Articles and recent verified events
- Remedy Robotics Introduces N1 System, Completes First Fully Remote Neurointerventional Procedures — 2025-10-06
- Remedy Robotics raises $35M Series A to scale remote surgical robotics platform — 2025-10-06
- Doctors in Toronto complete distant brain angiograms using the N1 system from Remedy Robotics — 2025-10-01